Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.

Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa and the Arabian Peninsula. The causative agent, Rift Valley fever phlebovirus (RVFV), belongs to the genus Phlebovirus in the family Phenuiviridae and causes high rates of abortions in ruminants, and hemorrhagic fever, en...

Full description

Bibliographic Details
Main Authors: Hoai J Ly, Nandadeva Lokugamage, Shoko Nishiyama, Tetsuro Ikegami
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2017-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC5604998?pdf=render
_version_ 1818765389303119872
author Hoai J Ly
Nandadeva Lokugamage
Shoko Nishiyama
Tetsuro Ikegami
author_facet Hoai J Ly
Nandadeva Lokugamage
Shoko Nishiyama
Tetsuro Ikegami
author_sort Hoai J Ly
collection DOAJ
description Rift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa and the Arabian Peninsula. The causative agent, Rift Valley fever phlebovirus (RVFV), belongs to the genus Phlebovirus in the family Phenuiviridae and causes high rates of abortions in ruminants, and hemorrhagic fever, encephalitis, or blindness in humans. Viral maintenance by mosquito vectors has led to sporadic RVF outbreaks in ruminants and humans in endemic countries, and effective vaccination of animals and humans may minimize the impact of this disease. A live-attenuated MP-12 vaccine strain is one of the best characterized RVFV strains, and was conditionally approved as a veterinary vaccine in the U.S. Live-attenuated RVF vaccines including MP-12 strain may form reassortant strains with other bunyavirus species. This study thus aimed to characterize the occurrence of genetic reassortment between the MP-12 strain and bunyavirus species closely related to RVFV. The Arumowot virus (AMTV) and Gouleako goukovirus (GOLV), are transmitted by mosquitoes in Africa. The results of this study showed that GOLV does not form detectable reassortant strains with the MP-12 strain in co-infected C6/36 cells. The AMTV also did not form any reassortant strains with MP-12 strain in co-infected C6/36 cells, due to the incompatibility among N, L, and Gn/Gc proteins. A lack of reassortant formation could be due to a functional incompatibility of N and L proteins derived from heterologous species, and due to a lack of packaging via heterologous Gn/Gc proteins. The MP-12 strain did, however, randomly exchange L-, M-, and S-segments with a genetic variant strain, rMP12-GM50, in culture cells. The MP-12 strain is thus unlikely to form any reassortant strains with AMTV or GOLV in nature.
first_indexed 2024-12-18T08:17:19Z
format Article
id doaj.art-2380ef1257f548e5b00e41747f6ceee4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-18T08:17:19Z
publishDate 2017-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2380ef1257f548e5b00e41747f6ceee42022-12-21T21:14:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01129e018519410.1371/journal.pone.0185194Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.Hoai J LyNandadeva LokugamageShoko NishiyamaTetsuro IkegamiRift Valley fever (RVF) is a mosquito-borne zoonotic disease endemic to Africa and the Arabian Peninsula. The causative agent, Rift Valley fever phlebovirus (RVFV), belongs to the genus Phlebovirus in the family Phenuiviridae and causes high rates of abortions in ruminants, and hemorrhagic fever, encephalitis, or blindness in humans. Viral maintenance by mosquito vectors has led to sporadic RVF outbreaks in ruminants and humans in endemic countries, and effective vaccination of animals and humans may minimize the impact of this disease. A live-attenuated MP-12 vaccine strain is one of the best characterized RVFV strains, and was conditionally approved as a veterinary vaccine in the U.S. Live-attenuated RVF vaccines including MP-12 strain may form reassortant strains with other bunyavirus species. This study thus aimed to characterize the occurrence of genetic reassortment between the MP-12 strain and bunyavirus species closely related to RVFV. The Arumowot virus (AMTV) and Gouleako goukovirus (GOLV), are transmitted by mosquitoes in Africa. The results of this study showed that GOLV does not form detectable reassortant strains with the MP-12 strain in co-infected C6/36 cells. The AMTV also did not form any reassortant strains with MP-12 strain in co-infected C6/36 cells, due to the incompatibility among N, L, and Gn/Gc proteins. A lack of reassortant formation could be due to a functional incompatibility of N and L proteins derived from heterologous species, and due to a lack of packaging via heterologous Gn/Gc proteins. The MP-12 strain did, however, randomly exchange L-, M-, and S-segments with a genetic variant strain, rMP12-GM50, in culture cells. The MP-12 strain is thus unlikely to form any reassortant strains with AMTV or GOLV in nature.http://europepmc.org/articles/PMC5604998?pdf=render
spellingShingle Hoai J Ly
Nandadeva Lokugamage
Shoko Nishiyama
Tetsuro Ikegami
Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
PLoS ONE
title Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
title_full Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
title_fullStr Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
title_full_unstemmed Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
title_short Risk analysis of inter-species reassortment through a Rift Valley fever phlebovirus MP-12 vaccine strain.
title_sort risk analysis of inter species reassortment through a rift valley fever phlebovirus mp 12 vaccine strain
url http://europepmc.org/articles/PMC5604998?pdf=render
work_keys_str_mv AT hoaijly riskanalysisofinterspeciesreassortmentthroughariftvalleyfeverphlebovirusmp12vaccinestrain
AT nandadevalokugamage riskanalysisofinterspeciesreassortmentthroughariftvalleyfeverphlebovirusmp12vaccinestrain
AT shokonishiyama riskanalysisofinterspeciesreassortmentthroughariftvalleyfeverphlebovirusmp12vaccinestrain
AT tetsuroikegami riskanalysisofinterspeciesreassortmentthroughariftvalleyfeverphlebovirusmp12vaccinestrain